Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories to Present at UBS Healthcare Services Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 10, 2006--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster and Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the UBS Global Healthcare Services Conference in New York, on Tuesday, February 14th, at 10:00 a.m. ET. Mr. Foster will present an overview of Charles River's business and strategic focus, and Mr. Ackerman will discuss the Company's recent financial performance and fiscal 2006 expectations.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay will be accessible through the same website approximately three hours after the presentation and will remain available through February 21, 2006.

CONTACT: Charles River Laboratories International, Inc.
Investor Relations Contact:
Susan E. Hardy, 781-262-7616
Corporate Vice President, Investor Relations
SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)